🔎 Trials Near Me

Dachaigh › Galar Crohn › Maryland

Sgrùdaidhean clionaigeach Galar Crohn ann an Maryland

Tha 15 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann an Maryland.

Bailtean ann an Maryland

Teacsa sgrùdaidh oifigeil (Beurla)

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07619547

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Walter Reed National Military Medical Center ( Site 5006), Bethesda
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Capital Digestive Care, Chevy Chase
  • Woodholme Gastroenterology, Glen Burnie
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Metropolitan Gastroenterology Group - Chevy Chase /ID# 265877, Chevy Chase
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • Woodholme Gastroenterology Associates, Glen Burnie
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Woodholme Gastroenterology Associates, Glen Burnie
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Chevy Chase Clinical Research, Chevy Chase
  • Woodholme Gastroenterology Associates, Glen Burnie
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Capital Digestive Care - Chevy Chase, Chevy Chase
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Mercy Medical Center, Baltimore-Site Number: 8400117, Baltimore
  • Mid-Atlantic GI Research, LLC-Site Number: 8400106, Laurel
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

  • National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT03167437

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Mercy Medical Center, Baltimore
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07237516

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • The Johns Hopkins Children's Medical Center, Baltimore
A’ fastadhÌre 4
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT05781152

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

  • Woodholme Gastroenterology Associates, Glen Burnie
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06764615

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Johns Hopkins University, Baltimore
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04779320

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.